Antony Mattessich | President and CEO |
Donald Notman | CFO |
Dr. Michael Goldstein | Chief Medical Officer |
Dr. Dan Bollag | SVP, Regulatory and Quality |
Kevin Hanley | SVP, Technical Operations |
Adnan Butt | Guggenheim Securities |
Dane Leone | BTIG |
Yi Chen | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix First Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session, and instructions will follow at that time. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutix.